Patents by Inventor Pier Andrea Gatti

Pier Andrea Gatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of enantiomerically pure norepinephrine
    Patent number: 11390579
    Abstract: The invention concerns a new, efficient process for the preparation of enantiomerically pure norepinephrine (also known as noradrenaline), or an addition salt thereof, using a catalytic hydrogenation system under hydrogen donor transfer. The invention also discloses a novel intermediate and the process for the preparation thereof.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: July 19, 2022
    Assignee: Edmond Pharma, s.r.l.
    Inventors: Matteo Zacche', Pier Andrea Gatti, Fulvio Gerli, Davide Sbarbada, Fabio Rondina
  • A PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE NOREPINEPHRINE
    Publication number: 20220089520
    Abstract: The invention concerns a new, efficient process for the preparation of enantiomerically pure norepinephrine (also known as noradrenaline), or an addition salt thereof, using a catalytic hydrogenation system under hydrogen donor transfer. The invention also discloses a novel intermediate and the process for the preparation thereof.
    Type: Application
    Filed: April 2, 2020
    Publication date: March 24, 2022
    Applicant: Edmond Pharma, s.r.l.
    Inventors: Matteo Zacche', Pier Andrea Gatti, Fulvio Gerli, Davide Sbarbada, Fabio Rondina
  • Process for the resolution of medetomidine and recovery of the unwanted enantiomer
    Patent number: 8877941
    Abstract: A new and efficient process to obtain Medetomidine enantiomers, a selective and potent ?2-receptor agonist, is presented. Such process comprises a resolution step and a racemization reaction, to be able to recover the unwanted enantiomer which can be recycled as starting material.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: November 4, 2014
    Assignee: Edmond Pharma S.r.l.
    Inventors: Matteo Zacche', Fulvio Gerli, Pier Andrea Gatti
  • PROCESS FOR THE RESOLUTION OF MEDETOMIDINE AND RECOVERY OF THE UNWANTED ENANTIOMER
    Publication number: 20130225832
    Abstract: A new and efficient process to obtain Medetomidine enantiomers, a selective and potent ?2-receptor agonist, is presented. Such process comprises a resolution step and a racemisation reaction, to be able to recover the unwanted enantiomer which can be recycled as starting material.
    Type: Application
    Filed: February 26, 2013
    Publication date: August 29, 2013
    Applicant: Edmond Pharma s.r.l.
    Inventors: Matteo Zacche', Fulvio Gerli, Pier Andrea Gatti
  • Polymorphs of enantiopure erdosteine
    Patent number: 8269022
    Abstract: The present invention provides novel crystalline polymorphs of enantiopure Erdosteine, referred to as Form I and Form II, and processes for the preparation thereof.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: September 18, 2012
    Assignee: Edmond Pharma S.R.L
    Inventors: Pier Andrea Gatti, Matteo Zacche′, Massimo Nicola
  • POLYMORPHS OF ENANTIOPURE ERDOSTEINE
    Publication number: 20100249435
    Abstract: The present invention provides novel crystalline polymorphs of enantiopure Erdosteine, referred to as Form I and Form II, and processes for the preparation thereof.
    Type: Application
    Filed: November 10, 2008
    Publication date: September 30, 2010
    Applicant: Edmond Pharma S.R.L
    Inventors: Pier Andrea Gatti, Matteo Zacche', Massimo Nicola
  • Heterocycle-condensed morphinoid derivatives (II)
    Patent number: 6365594
    Abstract: Heterocycle-condensed morphinoid derivatives of formula (I), or solvates or salts thereof, are potent and selective delta opioid agonists and antagonists and are useful as i.a. analgesics. Pharmaceutical compositions containing such compounds, the use of such compounds as therapeutic agents, a method of treatment comprising the administration of such compounds, and a process for the preparation of such compounds are also described.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: April 2, 2002
    Assignee: SmithKline Beecham S.p.A.
    Inventors: Giulio Dondio, Silvano Ronzoni, Pier Andrea Gatti, Davide Graziani